Results 261 to 270 of about 15,127 (297)
Some of the next articles are maybe not open access.
Clinical Reviews in Allergy & Immunology, 2000
The identification of the gene responsible for XLA has made it possible to clarify the clinical and laboratory findings in this disorder. It has markedly improved our ability to provide informative genetic counseling for affected families and it has helped unmask disorders that are clinically similar to XLA but genotypically different.
Jurg Rohrer +2 more
openaire +3 more sources
The identification of the gene responsible for XLA has made it possible to clarify the clinical and laboratory findings in this disorder. It has markedly improved our ability to provide informative genetic counseling for affected families and it has helped unmask disorders that are clinically similar to XLA but genotypically different.
Jurg Rohrer +2 more
openaire +3 more sources
The Journal of Pediatrics, 1957
Summary A case of agammaglobulinemia in a 5 1/2-year-old boy is presented. The gamma globulin level in the child's serum as determined by immunological method was extremely low, between 0.5 and 1 mg. per 100 ml. plasma, which is lower than in other cases reported in the literature.
openaire +3 more sources
Summary A case of agammaglobulinemia in a 5 1/2-year-old boy is presented. The gamma globulin level in the child's serum as determined by immunological method was extremely low, between 0.5 and 1 mg. per 100 ml. plasma, which is lower than in other cases reported in the literature.
openaire +3 more sources
SUCCESSFUL HOMOGRAFT OF SKIN IN A CHILD WITH AGAMMAGLOBULINEMIA
Journal of the American Medical Association, 1955A substantial obstacle to current medical and surgical progress is the established fact that tissues and organs from one person transplanted to another will not survive. Although it has been suspected that rejection of homografts has an immunologic basis, proof of this concept is lacking.
Robert A. Good, Richard L. Vareo
openaire +3 more sources
Pediatric Allergy and Immunology, 2020
Congenital agammaglobulinemia is the first primary immunodeficiency disorder characterized by a defect in B lymphocyte development and subsequently decreased immunoglobulin levels.
Saba Fekrvand +22 more
semanticscholar +1 more source
Congenital agammaglobulinemia is the first primary immunodeficiency disorder characterized by a defect in B lymphocyte development and subsequently decreased immunoglobulin levels.
Saba Fekrvand +22 more
semanticscholar +1 more source
Endocrine, Metabolic & Immune Disorders - Drug Targets, 2020
Agammaglobulinemia is a type of primary antibody deficiencies, characterized by severe reduction in serum level of all types of immunoglobulins level and absence of B cells in the peripheral blood.
S. Pashangzadeh +5 more
semanticscholar +1 more source
Agammaglobulinemia is a type of primary antibody deficiencies, characterized by severe reduction in serum level of all types of immunoglobulins level and absence of B cells in the peripheral blood.
S. Pashangzadeh +5 more
semanticscholar +1 more source
Agammaglobulinemia with polyarthritis and subcutaneous nodules [PDF]
The American Journal of Medicine, 1970 Abstract A case of agammaglobulinemia associated with polyarthritis and cutaneous nodules in a four year old boy is presented. Following extensive clinical, pathologic and serologic studies it was concluded that (1) the role of locally produced antibodies capable of complement fixation could not be excluded in the pathogenesis of the synovitis; (2 ...
Alan Winkelstein +2 more
openaire +2 more sources
Chest Disease in Patients with Agammaglobulinemia
Diseases of the Chest, 19561. Agammaglobulinemia—a relatively new disease is discussed from the standpoint of the chest physician. 2. Eight cases studied at the University of Minnesota during the past two years are briefly presented. 3. The available literature on agammaglobulinemia is reviewed to emphasize the importance of pulmonary manifestations in the clinical ...
Robert A. Good, William F. Mazzitello
openaire +3 more sources
Neutropenia in X-Linked Agammaglobulinemia
Clinical Immunology and Immunopathology, 1996X-linked agammaglobulinemia (XLA) is usually considered a disorder of B cell development; however, the gene that is defective in XLA encodes a cytoplasmic tyrosine kinase called Btk, that is expressed throughout myeloid as well as B cell differentiation. A review of medical records of patients in whom mutations in Btk had been identified indicated that
Jason E. Farrar +4 more
openaire +3 more sources
The clinical spectrum of bruton’s agammaglobulinemia
Current Allergy and Asthma Reports, 2001X-linked, or Bruton's, agammaglobulinemia (XLA) was described in 1952 as the congenital inability to form antibodies. Patients were typically infants or young children with recurrent, severe bacterial infections. Other, milder cases of hypogammaglobulinemia were considered "acquired," and often presented later in life.
D M Stewart, D L Nelson, L Lian
openaire +3 more sources